Abstract
β-Galactosidase (β-gal) has been widely used as a transgene reporter enzyme, and several substrates are available for its in vitro detection. The ability to image β-gal expression in living animals would further extend the use of this reporter. Here we show that DDAOG, a conjugate of β-galactoside and 7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacridin-2-one) (DDAO), is not only a chromogenic β-gal substrate but that the cleavage product has far-red fluorescence properties detectable by imaging. Importantly, the cleavage substrate shows a 50-nm red shift, enabling its specific detection in a background of intact probe, a highly desirable feature for in vivo imaging. Specifically, we show that β-gal-expressing 9L gliomas are readily detectable by red fluorescence imaging in comparison with the native 9L gliomas. We furthermore show that herpes simplex virus amplicon-mediated LacZ gene transfer into tumors can be transiently and thus serially visualized over time. The results indicated that in vivo real-time detection of β-gal activity is possible by fluorescence imaging technology.
Cite
CITATION STYLE
Tung, C. H., Zeng, Q., Shah, K., Kim, D. E., Schellingerhout, D., & Weissleder, R. (2004). In Vivo Imaging of β-Galactosidase Activity Using Far Red Fluorescent Switch. Cancer Research, 64(5), 1579–1583. https://doi.org/10.1158/0008-5472.CAN-03-3226
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.